Microdosing
Start low, go slow. A calm, medically supervised path to steadier energy, fewer cravings, and long‑term metabolic health.
Get startedAvg. weight reduction in GLP-1 trials*
Risk reduction in prediabetes studies*
Clinician reviewed
The service is designed for the moment when metabolism needs gentle support.
Provide information about your goals and medical history to fuel your metabolic health assessment.
A licensed healthcare provider carefully reviews your health information and determines whether treatment is appropriate.
.webp)
Providers may recommend prescription treatments from licensed pharmacies.
.webp)
Stay connected with your clinician as your plan evolves.
Provide information about your goals and medical history to fuel your metabolic health assessment.
A licensed healthcare provider carefully reviews each case and determines whether treatment is appropriate.
Providers may recommend prescription treatments from licensed pharmacies.
Stay connected with your clinician as your plan evolves.
A clinician-guided wellbeing program focused on mood, focus, and routines—using approaches that are legal and medically appropriate where you live.
Legality varies by location and treatment type. We only provide care that complies with local regulations and clinician licensing.
Eligibility depends on mental-health history, current medications, and goals. Some psychiatric histories may make microdosing inappropriate.
Medical intake and clinician review, a personalized plan when appropriate, and follow‑ups to monitor response and safety.
A microdose should not cause impairment. If you feel impaired or uncomfortable, stop and contact your care team.
Many people evaluate changes over several weeks. Effects are subtle for some people and not guaranteed.
Possible effects include anxiety, headache, sleep disruption, or GI upset. These are often related to dose or timing and can improve with adjustments.
Sometimes, but interactions and risks vary. Share your full medication list so your clinician can advise safely.
Avoid combining with recreational substances and avoid major medication changes without clinician guidance.
This is not a replacement for psychotherapy. If therapy is a better fit, we’ll recommend appropriate resources.
Pause and contact your care team. If you have severe anxiety, suicidal thoughts, hallucinations, or safety concerns, seek urgent help immediately.
Yes. You can stop at any time; let your clinician know so they can guide a safe transition.
Feeling hunger on semaglutide can be frustrating—especially if you expected “no appetite at all.” In reality, most people still feel some hunger. The goal is often less impulsive hunger and better control.
If hunger stays intense for weeks, you’re gaining weight unexpectedly, or side effects are severe, contact your clinician. Do not self-adjust dosing.
Starting a GLP-1 medication can feel exciting—and unfamiliar. This patient guide covers what to expect in your first phase of treatment and how to avoid common mistakes.
Many people notice appetite changes early, but side effects can also show up early. Small meals, adequate hydration, and consistent routines usually make the adjustment easier.
With a lower appetite, nutrition quality matters more. Prioritize protein, fiber, and nutrient-dense foods. If you’re eating less overall, “protein first” at meals is often a practical rule.
Mild nausea, constipation, or stomach discomfort can occur. But severe or persistent vomiting, signs of dehydration, or severe abdominal pain require medical attention. Don’t “push through” serious symptoms.
Weight loss is rarely linear. Plateaus do not necessarily mean treatment has failed. They may signal that habits, intake quality, activity, or clinical strategy needs adjustment.
If you’re using a vial and syringe, measuring correctly is critical. If you’re unsure how to measure a dose, contact your clinician or pharmacy before injecting.
The best outcomes come from medication + support: follow-ups, nutrition coaching, and a plan for travel, missed doses, and long-term maintenance.
GLP-1 medications are a class of prescription therapies used in metabolic health and, for appropriate patients, chronic weight management. They’re widely discussed because many patients experience meaningful appetite changes, better satiety, and improved consistency with nutrition plans—when the medication is paired with lifestyle support.
GLP-1 is a hormone pathway involved in appetite regulation and digestion. GLP-1 medications mimic aspects of this signaling, which can help reduce hunger, increase fullness, and support better control over eating patterns.
A licensed clinician determines eligibility based on weight, health history, and contraindications. This is not cosmetic care; it’s medical care intended for people who meet clinical criteria.
Many people notice appetite changes first. Weight change typically happens over time, not overnight, and plateaus are common. A responsible plan includes nutrition guidance (protein/fiber focus), hydration habits, and check-ins.
Gastrointestinal side effects can occur, especially early. Preparation helps: smaller meals, hydration, and a plan for nausea or constipation. If symptoms are severe or persistent, medical support is essential.
Some people ask about compounded options. Compounded drugs are not FDA-approved; dosing clarity and pharmacy standards matter. Your clinician should explain options and risks clearly.
If you’re exploring GLP-1 therapy, start with an eligibility review. The goal is to find the safest, most sustainable plan for your health—not just a quick result.
.webp)
.webp)